| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $2.4M | — | -32.1% |
| SG&A Expense | $2.3M | — | +16.6% |
| Operating Income | -$4.7M | — | +14.3% |
| Pre-tax Income | -$4.7M | — | +14.3% |
| Income Tax | $0 | — | — |
| Net Income | -$4.7M | — | +14.3% |
| EPS (Basic) | -$0.12 | — | +33.3% |
| EPS (Diluted) | -$0.12 | — | +33.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.0M | -53.4% | -53.6% |
| Inventory | $133K | +29.1% | — |
| Current Assets | $2.4M | -48.0% | -71.7% |
| Total Assets | $3.9M | -32.8% | -56.9% |
| Current Liabilities | $3.3M | +1.7% | +108.7% |
| Total Liabilities | $3.3M | +1.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.6M | — | +19.4% |
| Capital Expenditures | $246K | — | — |
| Investing Cash Flow | -$246K | — | +93.5% |
| Financing Cash Flow | $1.5M | — | -85.2% |
| Free Cash Flow | -$3.9M | — | +13.9% |
| +108.7% |
| Stockholders' Equity | $635K | -75.6% | -91.6% |